Paratek Pharmaceuticals I...

NASDAQ: PRTK · Real-Time Price · USD
2.23
0.04 (1.83%)
At close: Sep 20, 2023, 10:00 PM

Paratek Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2022 FY 2021
Period Ending Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
34.25M 80.37M
Short-Term Investments
n/a 15.11M
Long-Term Investments
n/a n/a
Other Long-Term Assets
32.47M 28.39M
Receivables
78.04M 33.12M
Inventory
16.57M 11.02M
Other Current Assets
7.87M 12.36M
Total Current Assets
136.84M 152.1M
Property-Plant & Equipment
2.4M 2.55M
Goodwill & Intangibles
829K 829K
Total Long-Term Assets
35.7M 31.77M
Total Assets
172.54M 183.87M
Account Payables
5.31M 5.39M
Deferred Revenue
n/a n/a
Short-Term Debt
n/a n/a
Other Current Liabilities
32.08M 25.9M
Total Current Liabilities
37.39M 31.3M
Long-Term Debt
258.41M 255.74M
Other Long-Term Liabilities
47.78M 24.62M
Total Long-Term Liabilities
306.19M 280.36M
Total Liabilities
343.58M 311.66M
Total Debt
258.41M 255.74M
Common Stock
56K 52K
Retained Earnings
-930.45M -866.88M
Comprehensive Income
n/a -9K
Shareholders Equity
-171.04M -127.79M
Total Investments
n/a 15.11M